Inappropriate chemotherapy decisions may occur through use of a commonly used formula that overestimates the risk of a cardiac adverse event, warn researchers. Many cancer drugs carry a risk of QT ...
Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer A database of 208 patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback